Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
72

Summary

Conditions
Endometriosis
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 45 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03749109
Collaborators
Not Provided
Investigators
Study Director: Global Clinical Compliance Ferring Pharmaceuticals